Oncternal Therapeutics, Inc.

The current price of ONCT is 8.77 USD — it has increased by 2.51% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Oncternal Therapeutics, Inc. stocks are traded under the ticker ONCT.

Oncternal Therapeutics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.

ONCT stock is 5.51% volatile and has beta coefficient of 2.42. Check out the list of the most volatile stocks — is Oncternal Therapeutics, Inc. there?

ONCT earnings for the last quarter are −3.40 USD per share, whereas the estimation was −2.90 USD resulting in a −17.24% surprise. The estimated earnings for the next quarter are −3.09 USD per share. See more details about Oncternal Therapeutics, Inc. earnings.

Oncternal Therapeutics, Inc. revenue for the last quarter amounts to ‪179.00 K‬ USD despite the estimated figure of ‪125.00 K‬ USD. In the next quarter revenue is expected to reach ‪128.00 K‬ USD.

Yes, you can track Oncternal Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

ONCT stock has risen by 0.57% compared to the previous week, the month change is a 7.55% rise, over the last year Oncternal Therapeutics, Inc. has showed a 27.77% increase.

Today Oncternal Therapeutics, Inc. has the market capitalization of ‪25.94 M‬, it has decreased by 1.61% over the last week.

No, ONCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, ONCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncternal Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

ONCT reached its all-time high on Apr 25, 2007 with the price of 33096.00 USD, and its all-time low was 5.22 USD and was reached on Apr 10, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 24, 2024, the company has 27.00 employees. See our rating of the largest employees — is Oncternal Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncternal Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncternal Therapeutics, Inc. stock shows the sell signal. See more of Oncternal Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Oncternal Therapeutics, Inc. future price: according to them, ONCT price has a max estimate of 39.00 USD and a min estimate of 25.00 USD. Read a more detailed Oncternal Therapeutics, Inc. forecast: see what analysts think of Oncternal Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Oncternal Therapeutics, Inc. EBITDA is ‪−41.57 M‬ USD, and current EBITDA margin is ‪−5.31 K‬%. See more stats in Oncternal Therapeutics, Inc. financial statements.